Study to determine if genotype determines response to AI's
 

Aromatase Inhibitor for Treatment of Resected Grade I, II or III Breast Cancer

This study is currently recruiting patients.
Verified by Mayo Clinic August 2006

Sponsors and Collaborators:Mayo Clinic M.D. Anderson Cancer Center
Information provided by:Mayo ClinicClinicalTrials.gov Identifier:NCT00366054
http://www.clinicaltrials.gov/html/images/arrow2.gif Purpose

Study to determine if genotype determines response to Aromatase Inhibitors ie: Decrease in hormone and drug levels.
Condition Breast Cancer